Stem cells are unspecialized cells that can develop into different types of cells which can be of same or different at the earlier stages of life and growth period. The property of forming various new cells has been widely used to treat many diseases and to produce a tissue or organ under conditions. Stem cells can produce cells that can cure diseases like spinal cord injury, diabetes, heart disorders and so on.
Asia Pacific Stem Cells Market Segments Size & Growth:
Asia PacificStem CellsMarket is accounted for $2.71billion in 2017 and expected to grow at a CAGR of 3.9% to reach $6 billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market growth an increasing demand for stem cell therapies, ability to treat various disorders, increase in ageing population, and rise in cancer cases. However, high cost for therapies and legal regulations hinder the growth of the Stem Cells market.
Asia Pacific Stem Cells Market Segments Share:
Asia PacificStem Cells Market is categorised into by treatment type which consists of syngeneic, allogeneic, and autologous
The autologous Stem cell therapy has the most significant share due to an increase in chronic diseases. By services, Stem Cells market is segmented as cryopreservation and stem cell banking. Among all stem cell banking are expected to have high growth rate during the forecast period 2018-2024, because of its application in the treatment of diabetes, cancer, autism, and leukaemia. The application is segregated into regenerative medicine, drug discovery and so on.Regenerative medicine is expected to have the most significant share in the market owing strong portfolio for cancer therapy in oncology by renewing the medicine.
By Geography, China is dominating the Stem Cells market, and the growth in the Asia Pacific is mainly attributed because of the increasing demand for personalised medicine and R&D activities. Furthermore, India is witnessing the fastest growth during the forecast period, due to rising ageing population, chronic diseases and investment in R&D research.
Asia Pacific Stem Cells Market Segments Trends:
- New techniques like Cellular barcoding helps the researcher understand the behaviour of stem cells, as
they can track and define family tree of individual blood cells in the environment.
Latest stem cell method sheds light on indicating the sign of heart diseases for the study of vascular diseases.
In February 2017, Takara Bio Holding, Inc. has wholly acquired WaferGen Bio-Systems, Inc. and has become the subsidiary of TBUSH.
Asia Pacific Stem Cells Research Report:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
- Regional and the Asia Pacific diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Cryo-Cell International
- Takara Holdings Inc.
- Stryker Corporation
- BIOTIME, INC.
- Invitrogen
